Measure Name: Acute Bronchitis Treatment without Antibiotics Measure Code: BRN Lab Data: N

Size: px
Start display at page:

Download "Measure Name: Acute Bronchitis Treatment without Antibiotics Measure Code: BRN Lab Data: N"

Transcription

1 Measure Name: Acute Bronchitis Treatment without Antibiotics Owner: NCQA (AAB) Measure Code: BRN Lab Data: N Rule Description: Applicable Provider Specialty: General Criteria Summary The percentage of adults years of age who had a diagnosis of acute bronchitis and were not dispensed an antibiotic prescription within three days of the encounter. Family Practice, Internal Medicine, Mixed Specialties Clinics, Allergy/Immunology, Pulmonary Diseases 1. Measurement period: 1 year prior to measurement period end date 2. Continuous enrollment: One year prior to the date of the acute bronchitis index encounter through 7 days following that date (373 days) 3. Index Episode based: Yes 4. Anchor date: Episode date 5. Gaps in enrollment: One 45-day gap allowed in the period of continuous enrollment 6. Medical coverage: Yes 7. Drug coverage: Yes 8. Attribution time frame: Episode date 9. Exclusions apply: None 10. Age range: Intake period: All but the last 7 days of the measurement year Summary of changes for In the denominator the following codes were added: HCPCS codes G0463 and T1015. These are all outpatient visit types. 2. In the comorbid conditions and competing diagnosis code lists, diagnoses that required additional digit(s) are removed. 3. Update AAB-D drug list (258 NDCs added and 206 removed) Denominator Description: All patients, aged 18 years as of the beginning of the year prior to the measurement year to 64 years as of the end of the measurement year, who had an outpatient or emergency department encounter with a diagnosis of acute bronchitis Inclusion Criteria: Patients as above with no comorbid condition during the twelve month period prior to the encounter, no prescription for an antibiotic medication filled 30 days prior to the encounter, and no competing diagnosis during the period from 30 days prior to the encounter to 7 days after the encounter. The intake period is from the beginning of the measurement year to 7 days prior to the end of the measurement year. Eligibility Criteria Condition Description # Evnt Detailed Criteria Field Name Dimen Table Name Fact Table Name Timeframe Age is 18 years or older Age in Years >= 18 age_years demog eligibility As of the beginning of the year prior to the measurement year

2 AND Age is 64 years or less Age in Years <= 64 age_years demog eligibility As of the end of the measurement year AND Has medical coverage Coverage Indicator Medical = Y medical_co vg_ind AND Has drug coverage Coverage Indicator Drug = Y drug_covg_ ind plan eligibility From 365 days prior to the date of the index encounter through 7 days following the date of the index encounter plan eligibility From 365 days prior to the date of the index encounter through 7 days following the date of the index encounter Claim Criteria Condition Description # Evnt Detailed Criteria Field Name Dimen Table Name At least one observation, outpatient or emergency department visit with a principal diagnosis of acute bronchitis (Note: Identify all visits that meet the above criteria. Check each visit against the remaining denominator inclusion criteria.) AND No history of a comorbid condition during the year prior to the bronchitis encounter AND No antibiotic medication prescribed or refilled within 30 days prior to the acute bronchitis visit or still active on the date of the visit 1 CPT Procedure Code= Outpatient, Observation, or ED Value Set HCPCS Procedure Code= Outpatient Value Set Revenue Code UB= Outpatient or ED Value Set) And Any Diagnosis Code = Acute Bronchitis Value Set) 1 All Diagnosis Codes <> HIV, Emphysema, COPD, Cystic Fibrosis, or Comorbid Conditions, Malignant Neoplasms Value Set 1 No new, refilled, or active drug prescriptions where NDC Number Code = Table AAB-D: Antibiotic Medications, HEDIS 2015,Table AAB-D and NDC list are available at Fact Table Name proc_cd proc fac_dtl prof_clm or proc_cd proc fac_dtl prof_clm or fac_revenue_cd proc fac_dtl dx_cd dx_cd dx any_dx dx any_dx fac_hdr prof_clm fac_hdr prof_clm Timeframe From the beginning of the measurement year to 7 days prior to the end of the measurement year From 12 months prior to the date of the acute bronchitis encounter through the date of the encounter ndc_nbr_cd drug drug_clm During the 90 day period prior to the acute bronchitis visit date (Note: 90 days is required to determine if there was a mail order prescription filled that is still active on the visit date.)

3 AND ement/hedismeasures/hedis2015/hedi S2015NDCLicense/HEDIS2015FinalNDCL ists.aspx A prescription is active if the prescription was filled more than 30 days prior to the bronchitis visit date and the Days Supply is greater than or equal to the number of days between the prescription fill date and the bronchitis visit date. No competing diagnosis from 30 days prior to the bronchitis encounter to 7 days after the encounter 1 All Diagnosis Codes <> Competing Diagnosis or Pharygitis Value Set dx_cd dx any_dx fac_hdr prof_clm From 30 days prior to the date of the acute bronchitis encounter through 7 days following the date of the encounter (Note: Identify all visits that meet the above criteria. Then select the visit with the earliest date and use that as the index encounter.) Numerator Description: For each patient who meets the denominator criteria, those who did not receive an antibiotic drug on or during the 3 day period following their acute bronchitis encounter Inclusion Criteria: Patients who did not have a prescription for an antibiotic drug on or up to three days following the date of their acute bronchitis index encounter Condition Description # Evnt Detailed Criteria Field Name Dimen Table Name No antibiotic medication dispensing events on or during the 3 day period following the date of the acute bronchitis index encounter 1 NDC Number Code <> Table AAB-D: Antibiotic Medications, HEDIS 2015,Table AAB-D and NDC list are available at ement/hedismeasures/hedis2015/hedi S2015NDCLicense/HEDIS2015FinalNDCL ists.aspx Fact Table Name Timeframe ndc_nbr_cd drug drug_clm On or during the 3 day period following the date of the index encounter

4 Notes: 1. In the denominator criterion that looks for at least one outpatient or emergency department encounter, a Place of Service criterion is not needed for the procedure codes or revenue codes because they are setting-specific. 2. For all criteria based on facility header attributes, the Date of First Service from the facility claim is used to determine whether the criteria falls within the indicated timeframe, unless otherwise specified. For outpatient claims, this is the service date. For inpatient claims, this is the admission date. 3. When determining whether a prescription is still active on the date of a visit, the date the prescription was filled is counted as the first day in which the days supply was used. In other words, it is assumed that the patient started taking the drug the same day that they filled the prescription. 4. When counting medication dispensing events or drug supply days, the following rules are used: a. Drug claims with a zero value for days supply are discarded and not counted as a medication dispensing event or used in determining if a prescription is still active on a particular date. b. Any drug claim with a negative days supply value is assumed to be an adjustment record. With all adjustment claims, an attempt is made to match it to the original claim, using Person ID, service date, and NDC code: i. If no match is found, the adjustment claim is discarded. ii. If a match is found, the days supply on the adjustment claim is summed with the days supply on the original claim. If the sum <= 0, both are discarded. If the sum > 0, the adjusted value is used for the original claim and the adjustment record is discarded. c. Two drug claims with a positive days supply for the same patient on the same day for the same NDC code are combined and treated as a single claim: i. The days_supply_cnt fields from both claim rows are summed. ii. If only one of the claim rows has non-missing, non-null provider information (i.e., prov_key, ordering_prov_key values), the information from that claim is used. iii. If both claim rows have non-missing, non-null provider information, the provider information from the claim with the largest days_supply_cnt is used. iv. If both claim rows have non-missing, non-null provider information and the days_supply_cnt values are the same, the provider information from the claim with the smallest prov_key value is used. 5. The intake period is 7 days less than a full year. For example, if the measurement year starts on January 1, the intake period runs from January 1 through December In 2014, new Value Sets for codes were implemented. 7. In 2014, the following codes were added to the denominator: CPT , , 99387, , 99397, 99455, and 99456; and, HCPCS codes G0204, G0438, and G0439. These are all visit types. 8. In 2015, following codes were added to the denominator: HCPCS codes G0463 and T1015. These are all outpatient visit types. 9. In 2015, within the comorbid conditions and competing diagnosis code lists, many codes without a fourth digit (ie. 001) were dropped. Appendix AAB-D: Antibiotic Medications Description Prescription Aminoglycosides Amikacin Kanamycin Tobramycin

5 Gentamicin Streptomycin Aminopenicillins Amoxicillin Ampicillin Antipseudomonal penicillins Beta-lactamase inhibitors Piperacillin Amoxicillin-clavulanate Ampicillin-sulbactam Piperacillintazobactam Ticarcillin-clavulanate First generation cephalosporins Cefadroxil Cefazolin Cephalexin Fourth generation cephalosporins Ketolides Cefepime Telithromycin Lincomycin derivatives Clindamycin Lincomycin Macrolides Miscellaneous antibiotics Natural penicillins Azithromycin Clarithromycin Aztreonam Chloramphenicol Dalfopristinquinupristin Penicillin G benzathine-procaine Penicillin G potassium Erythromycin Erythromycin ethylsuccinate Daptomycin Erythromycin-sulfisoxazole Linezolid Penicillin G procaine Penicillin G sodium Penicillinase resistant penicillins Dicloxacillin Nafcillin Oxacillin Quinolones Rifamycin derivatives Second generation cephalosporin Ciprofloxacin Gemifloxacin Rifampin Cefaclor Cefotetan Levofloxacin Moxifloxacin Cefoxitin Cefprozil Sulfonamides Sulfadiazine Sulfamethoxazoletrimethoprim Erythromycin lactobionate Erythromycin stearate Metronidazole Vancomycin Penicillin V potassium Penicillin G benzathine Norfloxacin Ofloxacin Cefuroxime Tetracyclines Doxycycline Minocycline Tetracycline Third generation cephalosporins Urinary anti-infectives Cefdinir Cefditoren Cefixime Cefotaxime Cefpodoxime Ceftazidime Ceftibuten Ceftriaxone Fosfomycin Nitrofurantoin macrocrystals-monohydrate Nitrofurantoin Trimethoprim Nitrofurantoin macrocrystals

6 Observation Value Set Code Code Type Description CPT Observation Care Discharge CPT Observation Care Outpatient Value Set Code Code Type Description CPT Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care CPT Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; Straightforward medical decision making CPT Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A detailed history; A detailed examination; Medical decision making of low complexity CPT Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity CPT Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity CPT Office or other outpatient visit for the evaluation and management of an established patient, that may not require the presence of a physician. Usually, the presenting problem(s) are minimal. Typically, 5 minutes CPT Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making CPT Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; CPT Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity CPT Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity CPT Observation care discharge day management (This code is to be utilized by the physician to report all services provided to a patient on discharge from "observation status" if the discharge is on other than the initial date of "observation status." CPT Initial observation care, per day, for the evaluation and management of a patient which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward CPT Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity CPT Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity.

7 99241 CPT Office consultation for a new or established patient, which requires these 3 key components: A problem focused history; A problem focused examination; and Straightforward medical decision making CPT Office consultation for a new or established patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; and Straightforward medical decision making CPT Office consultation for a new or established patient, which requires these 3 key components: A detailed history; A detailed examination; and Medical decision making of low complexity. Counseling and/or coordination of care with other providers or agencies CPT Office consultation for a new or established patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other providers CPT Office consultation for a new or established patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other providers CPT Home Visit - New Patient CPT Home Visit - Est Patient CPT Init Pm E/M - New Pat - Inf CPT Init Pm E/M - New Pat 1-4 Yrs CPT Prev Visit - New - Age CPT Prev Visit - New - Age CPT Prev Visit - New - Age CPT Prev Visit - New - Age CPT Init Pm E/M - New Pat 65+ Yrs CPT New patient, years, Initial comprehensive preventive medicine E&M including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of appropriate immunization CPT New patient, years, Initial comprehensive preventive medicine E&M including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of appropriate immunization CPT Per Pm Reeval - Est Pat Inf CPT Prev Visit - Est - Age CPT Prev Visit - Est - Age CPT Prev Visit - Est - Age CPT Prev Visit - Est - Age CPT Prev Visit - Est - Age CPT Per Pm Reeval Est Pat 65+ Yr CPT Established patient, years, Periodic comprehensive preventive medicine ree&m including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of appropriate immunization CPT Established patient, years, Periodic comprehensive preventive medicine E&M including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of appropriate immunization CPT Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approx 15 minutes CPT Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approx 30 minutes CPT Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approx 45 minutes

8 99404 CPT Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approx 60 minutes CPT Preventive medicine counseling and/or risk factor reduction intervention(s) provided to individuals in a group setting (separate procedure); approximately 30 minutes CPT Preventive medicine counseling and/or risk factor reduction intervention(s) provided to individuals in a group setting (separate procedure); approximately 60 minutes CPT Administration and interpretation of health risk assessment instrument (eg, health hazard appraisal) CPT Unlisted preventive medicine service CPT Work Related Disability Exam CPT Disability Examination G0402 HCPCS Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment G0438 HCPCS Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit G0439 HCPCS Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit G0463 HCPCS Hospital outpatient clinic visit for assessment and management of a patient T1015 HCPCS Clinic visit/encounter, all-inclusive 0510 UB Revenue CLINIC 0511 UB Revenue CHRONIC PAIN CL 0512 UB Revenue DENTAL CLINIC 0513 UB Revenue PSYCH CLINIC 0514 UB Revenue OB-GYN CLINIC 0515 UB Revenue PEDS CLINIC 0516 UB Revenue URGENT CLINIC 0517 UB Revenue FAMILY CLINIC 0519 UB Revenue OTHER CLINIC 0520 UB Revenue FREESTAND CLINIC 0521 UB Revenue RURAL/CLINIC 0522 UB Revenue RURAL/HOME 0523 UB Revenue FR/STD 0526 UB Revenue FR/STD URGENT CLINIC 0527 UB Revenue FR/STD 0528 UB Revenue FR/STD 0529 UB Revenue OTHER FR/STD CLINIC 0981 UB Revenue PRO/ER 0982 UB Revenue PRO FEE/OUTPT 0983 UB Revenue PRO FEE/CLINIC

9 ED Value Set Code Code Type Description CPT ED visit for E&M, which requires these 3 key components: A problem focused history; A problem focused examination; and Straightforward medical decision making. Counseling and/or coordination of care, self limited or minor problems CPT ED for E&M, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; and Medical decision making of low complexity. Counseling and/or coordination of care, low to moderate severity CPT ED visit for E&M, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care, moderate severity CPT ED visit for E&M, which requires these 3 key components: A detailed history; A detailed examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care, high severity CPT ED visit for E&M, which requires these 3 key components within the constraints imposed by the urgency of the patient's clinical condition and/or mental status: A comprehensive history; high severity with threat to life 0450 UB Revenue EMERG ROOM 0451 UB Revenue ER/EMTALA 0452 UB Revenue ER/BEYOND EMTALA 0456 UB Revenue URGENT CARE 0459 UB Revenue OTHER EMER ROOM 0981 UB Revenue PRO FEE/ER Acute Bronchitis Value Set Description Acute bronchitis Pharyngitis Value Set Description Strep sore throat 462 Acute pharyngitis 463 Acute tonsillitis HIV Value Set Description 042 Human immuno virus dis V08 Asymp hiv infectn status

10 Cystic Fibrosis Value Set Description , Cystic fibrosis Malignant Neoplasms Value Set Description 140.0, , 140.8, Malignant neoplasm of lip , 141.8, Malignant neoplasm of tongue , 142.8, Malignant neoplasm of major salivary glands 143.0, 143.1, 143.8, Malignant neoplasm of gum 144.0, 144.1, 144.8, Malignant neoplasm of floor of mouth , 145.8, Malignant neoplasm of other and unspecified parts of mouth Malignant neoplasm of oropharynx , 147.8, Malignant neoplasm of nasopharynx , 148.8, Malignant neoplasm of hypopharynx 149.0, 149.1, 149.8, Malignant neoplasm of other and ill-defined sites with in the kip, oral cavity, and pharynx , 150.8, Malignant neoplasm of esophagus , 151.8, Malignant neoplasm of stomach , 152.8, Malignant neoplasm of small intestine, including duodenum Malignant neoplasm of colon , Malignant neoplasm of rectum, rectosigmoid junction, and anus Malignant neoplasm of liver and interhepatic bile ducts , 156.8, Malignant neoplasm of gallbladder and extrahepatic bile ducts , 157.8, Malignant neoplasm of pancreas 158.0, 158.8, Malignant neoplasm of retroperitoneum and peritoneum 159.0, 159.1, 159.8, Malignant neoplasm of other and ill-defined sites within the digestive organs and peritoneum , 160.8, Malignant neoplasm of nasal cavities, middle ear, and accessory sinuses , 161.8, Malignant neoplasm of larynx 162.0, , 162.8, Malignant neoplasm of trachea, bronchus, and lung 163.0, 163.1, 163.8, Malignant neoplasm of pleura , 164.8, Malignant neoplasm of thymus, heart, and mediastinum 165.0, 165.8, Malignant neoplasm of other ill-defined sites within the respiratory system and intrathoracic organs Malignant neoplasm of bone and articular cartilage Malignant neoplasm of connective and other soft tissue Malignant melanoma of skin , , , , Other and unspecified malignant neoplasm of the skin , , , , , ,

11 , 174.8, Malignant neoplasm of female breast 175.0, Malignant neoplasm of male breast Kaposi's sarcoma 179 Malignant neoplasm of uterus-part unspecified 180.0, 180.1, 180.8, Malignant neoplasm of cervix uteri 181 Malignant neoplasm of placenta 182.0, 182.1, Malignant neoplasm of body of uterus 183.0, , 183.8, Malignant neoplasm of ovary and other uterine adnexa , 184.8, Malignant neoplasm of other and unspecified female genital organs 185 Malignant neoplasm of prostate 186.0, Malignant neoplasm of testis Malignant neoplasm of penis and other male genital organs Malignant neoplasm of bladder Malignant neoplasm of kidney and other and unspecified urinary organs Malignant neoplasm of eye Malignant neoplasm of brain , 192.8, Malignant neoplasm of other and unspecified parts of the nervous system 193 Malignant neoplasm of thyroid gland , 194.8, Malignant neoplasm of other endocrine glands and related structures , Malignant neoplasm of other and ill-defined sites , 196.5, 196.6, 196.8, Secondary and unspecified malignant neoplasm of lymph nodes Secondary malignant neoplasm of respiratory and digestive systems , , , Secondary malignant neoplasm of other specified sites 199.0, 199.1, Malignant neoplasm without specification of site , , , , Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue , , , , , , , , Hodgkin's disease , , , , , , , Other malignant neoplasms of lymphoid and histiocytic tissue , , , , , , , Multiple myeloma and immunoproliferative neoplasms , , , , Lymphoid leukemia , , , , Myeloid leukemia , , , , , Monocytic leukemia , , , Other specified leukemia

12 , , , , , , , , , , , Leukemia of unspecified cell type Neuroendocrine tumors Emphysema Value Set Description 492.0, Emphysema COPD Value Set Description Chronic obstructive asthma 496 Chronic airway obstruction not elsewhere classified Comorbid Conditions Value Set Description , , , 279.2, 279.3, , Disorders involving the immune mechanism , 279.8, , 491.1, , 491.8, Chronic bronchitis 494.0, Bronchiectasis Extrinsic allergic alveolitis 500 Coal workers' pneumoconiosis 501 Asbestosis 502 Pneumoconiosis due to other silica or silicates 503 Pneumoconiosis due to other inorganic dust 504 Pneumonopathy due to inhalation of other dust 505 Pneumoconiosis unspecified , Respiratory conditions due to chemical fumes and vapors 507.0, 507.1, Pneumonitis due to solids and liquids , 508.8, Respiratory conditions due to other and unspecified external agents 510.0, Empyema 511.0, 511.1, , , Pleurisy , , Pneumothorax 513.0, Abscess of lung and mediastinum 514 Pulmonary congestion and hypostasis 515 Postinflammatory pulmonary fibrosis , , 516.4, 516.5, , , Other alveolar and parietoalveolar pneumonopathy 516.8, 516.9

13 , Lung involvement in conditions classified elsewhere , , 518.6, 518.7, , Other diseases of the lung , , , , , 519.8, Other diseases of respiratory system , , , Primary tuberculous infection , , , , Pulmonary tuberculosis , , , , , , , , , Other respiratory tuberculous , , , , Tuberculous of meninges and central nervous system , , , , , Tuberculous of intestines, peritoneum, and mesenteric glands , , , , Tuberculosis of bones and joints , , , , , , , Tuberculosis of genitourinary system , , , , , , , , Tuberculosis of other organs , , , , , , , Miliary tuberculosis Competing Diagnosis Value Set Description: Intestinal infections 001.0, 001.1, Cholera , Typhoid and paratyphoid fevers 003.0, 003.1, , , 003.8, Other salmonella infections , 004.8, Shigellosis , , , Other food poisoning (bacterial) , 006.8, Amebiasis , 007.8, Other protozoal intestinal diseases , , , , , 008.5, Intestinal infection due to other organisms , , Ill-defined intestinal infections Description: Pertussis 033.0, 003.1, 003.8, Whooping cough Description: Bacterial infection unspecified Bacterial infection unspecified in conditions classified elsewhere and of unspecified site

14 Description: Lyme disease and other arthropod-borne diseases 088.0, , , , Other arthropod-borne diseases Description: Otitis media , , Suppurative and unspecified otitis media Description: Acute sinusitis , 461.8, Acute sinusitis Description: Acute pharyngitis 462 Acute pharyngitis Streptococcal sore throat Description: Acute tonsillitis 463 Acute tonsillitis Description: Chronic sinusitis , 473.8, Chronic sinusitis Description: Infections of the pharynx, larynx, tonsils, adenoids , Acute tracheitis , Acute laryngotracheitis , Acute epiglottitis , , 474.2, 474.8, Chronic disease of tonsils and adenoids Cellulitis of pharynx or nasopharynx Parapharyngeal abscess Retropharyngeal abscess Other diseases of pharynx or nasopharynx Cellulitis and perichondritis of larynx Other diseases of larynx Other and unspecified diseases of upper respiratory tract Description: Prostatitis , 601.8, Inflammatory diseases of prostate Description: Cellulitis, mastoiditis, other bone infections , 383.1, , , , , Mastoiditis and related conditions , , , Cellulitis and abscess of finger and toe Other cellulitis and abscess , Osteomyelitis, periostitis, and other infections involving bone Description: Acute lymphadenitis 683 Acute lymphadenitis Description: Impetigo 684 Impetigo Description: Skin staph infections

15 686.00, , 686.1, 686.8, Other local infections of skin and subcutaneous tissue Description: Pneumonia 481 Pneumococcal pneumonia 482.0, 482.1, 482.2, , , , Other bacterial pneumonia , , , 483.1, Pneumonia due to other specified organism 484.1, 484.3, 484.5, Pneumonia in infectious diseases classified elsewhere 485 Bronchopneumonia organism unspecified 486 Pneumonia organism unspecified Description: Gonococcal infections and venereal diseases 098.0, , , 098.2, , , Gonococcal infections , , 098.6, 098.7, , , , , , , 099.8, Other venereal diseases V01.6 Contact with or exposure to venereal diseases V02.7 Contact with or exposure to other viral diseases V02.8 Veneral disease carrier NEC Description: Syphilis , , , Congenital syphilis , , , , , 091.7, , Early syphilis, symptomatic , , , Early syphilis, latent 093.0, 093.1, , , , , Cardiovascular syphilis , , , Neurosyphilis Other forms of late syphilis, with symptoms 096 Late syphilis, latent 097.0, 097.1, Other and unspecified syphilis 098.0, , , 098.2, , , Gonococcal infections , , , 098.6, 098.7, , , , , , , 099.8, Other venereal diseases Description: Chlamydia Other specified diseases due to chlamydiae Other specified chlamydial infection Unspecified chlamydial infection Description: Inflammatory diseases (female reproductive organs) , 131.8, Trichomoniasis Inflammatory disease of ovary, fallopian tube, pelvic cellular tissue, and peritoneum 615.0, 615.1, Inflammatory diseases of uterus, except cervix 616.0, , , , , , , , Inflammatory disease of cervix, vagina, and vulva 616.9

16 Description: Infections of the kidney , , , , 590.2, 590.3, , , Infections of kidney Description: Cystitis or UTI , , , , Cystitis Urinary tract infection, site not specified Description: Acne Acne varioliformis Other acne

NCQA that the exclusion still applies.

NCQA that the exclusion still applies. Measure Name: Pharyngitis Treatment for Children Owner: NCQA (CWP) Measure Code: PHR Lab Data: Y Rule Description: The percentage of children 2-18 years of age who were diagnosed with pharyngitis, dispensed

More information

2019 PHP PRIMARY CARE INCENTIVE

2019 PHP PRIMARY CARE INCENTIVE Primary Care Physicians (PCP) of Physicians Health Network (PHN) may be eligible for an incentive payment in accordance with this PHP PCP Incentive (hereinafter referred to as the PCP Incentive ). As described

More information

3/26/2015 Page 1. Detailed Criteria Field Name Dimen Table Name. Timeframe. Condition Description. Fact Table Name. # Evnt

3/26/2015 Page 1. Detailed Criteria Field Name Dimen Table Name. Timeframe. Condition Description. Fact Table Name. # Evnt Measure : Low Back Pain Imaging Studies Owner: NCQA (LBP) Measure : LBP Lab Data: N Rule : The percentage of patients 18-50 years of age who had a principal diagnosis of low back pain and who did not have

More information

Quality measures a for measurement year 2016

Quality measures a for measurement year 2016 Quality measures a for measurement year 2016 Measure Description Eligible members Childhood immunizations b Adolescent immunizations b Children who turned 2 during the measurement and who were identified

More information

Cancer in Estonia 2014

Cancer in Estonia 2014 Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National

More information

ACHA Clinical Benchmarking Program

ACHA Clinical Benchmarking Program Acute Care Measure: Avoidance of Antibiotic Treatment for Adults Aged 18-64 with Acute Bronchitis Background The American College of Chest Physicians defines acute bronchitis as "an acute respiratory infection

More information

S2 File. Clinical Classifications Software (CCS). The CCS is a

S2 File. Clinical Classifications Software (CCS). The CCS is a S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)

More information

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to: DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded

More information

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to: WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not

More information

ANNUAL CANCER REGISTRY REPORT-2005

ANNUAL CANCER REGISTRY REPORT-2005 ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males

More information

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional

More information

APPENDIX ONE: ICD CODES

APPENDIX ONE: ICD CODES APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding

More information

Cause of death in SMHS (05/16/2017)

Cause of death in SMHS (05/16/2017) Cause of death in SMHS (05/16/2017) death_cause Frequency Percent Cumulative Frequency Cumulative Percent Primary tuberculous infection 1 0.02 1 0.02 Pulmonary tuberculosis 12 0.20 13 0.22 Tuberculosis

More information

TABLE C-1 RESIDENT DEATHS, LIVE BIRTHS, FETAL, INFANT, NEONATAL, AND MATERNAL DEATHS: PENNSYLVANIA,

TABLE C-1 RESIDENT DEATHS, LIVE BIRTHS, FETAL, INFANT, NEONATAL, AND MATERNAL DEATHS: PENNSYLVANIA, TABLE C-1 RESIDENT DEATHS, LIVE BIRTHS, FETAL, INFANT, NEONATAL, AND MATERNAL DEATHS: PENNSYLVANIA, 1950-1997 - TOTAL LIVE FETAL INFANT NEONATAL MATERNAL DEATHS BIRTHS DEATHS DEATHS DEATHS DEATHS ----------------------------------------------------------------------------------

More information

Cause of death in SWHS (05/16/2017)

Cause of death in SWHS (05/16/2017) death_cause Cause of death in SWHS (05/16/2017) Frequency Percent Cumulative Frequency Cumulative Percent Cholera 1 0.01 1 0.01 Typhoid and paratyphoid fevers 1 0.01 2 0.03 Other salmonella infections

More information

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients

More information

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care. Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and

More information

All Discovered Death Outcome Detail (Form 124/120)

All Discovered Death Outcome Detail (Form 124/120) This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877

More information

Florida Cancer Data System STAT File Documentation Version 2019

Florida Cancer Data System STAT File Documentation Version 2019 Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status

More information

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant

More information

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files By Dr. Martin A. Whiteside Director, Office of Cancer

More information

APPENDIX A. Comparability Ratios for the Major Causes of Death in North Carolina Vital Statistics, Volume 2

APPENDIX A. Comparability Ratios for the Major Causes of Death in North Carolina Vital Statistics, Volume 2 APPENDIX A Comparability Ratios for the Major Causes of Death in North Carolina Vital Statistics, Volume 2 The comparability ratio is an adjustment factor that is applied to the number of deaths coded

More information

2016 Cancer Registry Annual Report

2016 Cancer Registry Annual Report 2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,

More information

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5). Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.

More information

SUPPLEMENTAL MATERIAL. Table 1: International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) codes identifying

SUPPLEMENTAL MATERIAL. Table 1: International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) codes identifying SUPPLEMENTAL MATERIAL Table 1: International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) codes identifying variables used to calculate propensity scores Medical Conditions

More information

Non-covered ICD-10-CM Codes for All Lab NCDs

Non-covered ICD-10-CM Codes for All Lab NCDs Non-covered ICD-10-CM s for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the test,

More information

2012 Cancer Report 2011 Registry Data

2012 Cancer Report 2011 Registry Data 2012 Cancer Report 2011 Registry Data Contents Goals and Objectives 1 2012 Cancer Committee Members 2 Total Cancer Cases 1981-2011 3 Cancer Registry Frequency Report 1981-2011 4-5 Cancer Registry Frequency

More information

Chapter II: Overview

Chapter II: Overview : Overview Chapter II: Overview This chapter provides an overview of the status of cancer in Minnesota, using cases reported to the Minnesota Cancer Surveillance System (MCSS) and deaths reported to the

More information

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected

More information

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Date: 10 th April 2018 DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Request: 1. Utilization Data of Overseas Beam Therapy and Brachytherapy 2. Diagnoses Data of Overseas Claims for Beam Therapy and Brachytherapy

More information

From A to Z-Codes Matter

From A to Z-Codes Matter From A to Z-Codes Matter Susan Wallace, MEd, RHIA, CCS, CDIP, CCDS, FAHIMA While ALL ICD-10-CM codes are important, the Z-codes in ICD-10-CM are frequently considered step-children, supplemental codes

More information

Nov FromAtoZCodesMatter

Nov FromAtoZCodesMatter Nov 2017 FromAtoZCodesMatter From A to Z-Codes Matter Susan Wallace, MEd, RHIA, CCS, CDIP, CCDS, FAHIMA The implementation of ICD-10 brought tens of thousands of new codes. Ranging from A to Z, they portray

More information

Non-covered ICD-10-CM Codes for All Lab NCDs

Non-covered ICD-10-CM Codes for All Lab NCDs Non-covered ICD-10-CM s for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the test,

More information

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung 82330 CALCIUM; IONIZED ICD-10 Codes that Support Medical Necessity ICD-10 Code Description A15.0 Tuberculosis of lung A15.4 Tuberculosis of intrathoracic lymph nodes A15.5 Tuberculosis of larynx, trachea

More information

0301 Anemia Others. Endocrine nutritional and metabolic disorders Others Vascular dementia and unspecified dementia

0301 Anemia Others. Endocrine nutritional and metabolic disorders Others Vascular dementia and unspecified dementia Certain infectious and parasitic diseases 0101 Intestinal infectious diseases 0102 Tuberculosis 0103 Infections with a predominantly sexual mode of transmission 0104 Viral infections characterized by skin

More information

*

* Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The

More information

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15 1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1

More information

incidence rate x 100,000/year

incidence rate x 100,000/year Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European

More information

Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute

Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Paul R. Yarnold, Ph.D. and Robert C. Soltysik, M.S. Optimal Data Analysis, LLC Imagine a random sample

More information

Selected tables standardised to Segi population

Selected tables standardised to Segi population Selected tables standardised to Segi population LIST OF TABLES Table 4.2S: Selected causes of death, all-ages, 2000 2004 (Segi Standard) Table 5.3S: Public hospitalisations by major cause of admission

More information

Cancer Program Report 2014

Cancer Program Report 2014 Cancer Program Report 2014 Queen of the Valley Hospital St Joseph Health Queen of the Valley Hospital - 2014 Site Table Site Total Class Sex Group Cases Analytic NonAn M F 0 I II ALL SITES 661 494 167

More information

Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus

Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus Republican Research and Practical Center for Radiation Medicine and Human Ecology Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus The contaminated area in the Republic of Belarus consisted

More information

Cancer survival in Shanghai, China,

Cancer survival in Shanghai, China, Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely

More information

Measure Name: Prostate Cancer: Cancer Surveillance Owner: NQF (#625) Steward: Active Health Management

Measure Name: Prostate Cancer: Cancer Surveillance Owner: NQF (#625) Steward: Active Health Management Measure : Prostate Cancer: Cancer Surveillance Owner: NQF (625) Measure Code: PRS Rule : Applicable Provider Specialty: General Criteria Summary Steward: Active Health Management Lab Data: Y Percentage

More information

John R. Marsh Cancer Center

John R. Marsh Cancer Center John R. Marsh Cancer Center Lung Program Overview: 2014-2015 Initiatives Lung CT Screening Dr. Gregory Zimmerman In cooperation with The Lung Cancer Steering Committee, Diagnostic Imaging Services at the

More information

HCPCS Codes (Alphanumeric, CPT AMA) ICD-9-CM Codes Covered by Medicare Program

HCPCS Codes (Alphanumeric, CPT AMA) ICD-9-CM Codes Covered by Medicare Program HCPCS s (Alphanumeric, CPT AMA) 82272 Blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screening ICD-9-CM

More information

GLOBAL P4P. Pay for Performance (P4P) Program Guide

GLOBAL P4P. Pay for Performance (P4P) Program Guide GLOBAL P4P Pay for Performance (P4P) Program Guide Contact: QualityPrograms@iehp.org Published: March 28, 2018 PROGRAM OVERVIEW This program guide provides an overview of the 2018 Global Quality Pay for

More information

Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green

Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Digestive system 1. Teeth Main points: external and internal structure of a tooth, fixation of a tooth

More information

USAID Health Care Improvement Project. pneumonia) respiratory infections through improved case management (amb/hosp)

USAID Health Care Improvement Project. pneumonia) respiratory infections through improved case management (amb/hosp) Improvement objective: : decrease morbidity and mortality due to acute upper (rhinitis, sinusitis, pharyngitis) and lower (bronchitis, pneumonia) respiratory infections through improved case management

More information

POLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

POLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS POLICY F TREATMENT OF UPPER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: July 2013 Approved by: The Drugs & Therapeutics Committee Date: April 2016 Implementation

More information

NCD for Fecal Occult Blood Test

NCD for Fecal Occult Blood Test NCD for Fecal Occult Blood Test Applicable CPT Code(s): 82272 Blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal

More information

Serum Iron Studies

Serum Iron Studies 190.18 - Serum Iron Studies Serum iron studies are useful in the evaluation of disorders of iron metabolism, particularly iron deficiency and iron excess. Iron studies are best performed when the patient

More information

Attending Physician s Statement

Attending Physician s Statement ( Form A A This form is used for claiming the social insurance benefit. This form should be completed and signed by the attending physician outpatient and One form for each month, one form for hospitalization

More information

Non-covered ICD-10-CM Codes for All Lab NCDs

Non-covered ICD-10-CM Codes for All Lab NCDs Non-covered ICD-10-CM Codes for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the

More information

Cancer in Utah: An Overview of Cancer Incidence and Mortality from

Cancer in Utah: An Overview of Cancer Incidence and Mortality from Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.

More information

Medications currently available to treat Multiple Myeloma include: Current Code Price (AWP) Effective Date. Code Price (AWP)

Medications currently available to treat Multiple Myeloma include: Current Code Price (AWP) Effective Date. Code Price (AWP) drug and administration compendia Compendia information developed and maintained by With each publication Managed Care Oncology s Drug & Compendia will highlight a single medication or a group of medications

More information

Appendix 1. DATA SOURCES. A. Data on Recipients of Aid to Families with Dependent Children

Appendix 1. DATA SOURCES. A. Data on Recipients of Aid to Families with Dependent Children Appendix 1. DATA SOURCES A. Data on Recipients of Aid to Families with Dependent Children The data on the characteristics of AFDC recipients come from two sources. The race share of adult and child recipients

More information

CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster

CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster CHAPTER 10 CANCER REPORT Jeremy Chapman and Angela Webster CANCER REPORT ANZDATA Registry 2004 Report This report summarises the cancer (excluding nonmelanocytic skin cancer) experience of patients treated

More information

Premium Specialty: Pediatrics

Premium Specialty: Pediatrics Premium Specialty: Pediatrics Credentialed Specialties include: Adolescent Medicine, Pediatric Adolescent, and Pediatrics This document is designed to be used in conjunction with the UnitedHealth Premium

More information

HUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014

HUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014 HUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014 COMMISSION ON CANCER STANDARD 1.12 Hunt Cancer Institute Mission Statement To be first in the South Bay/Peninsula communities in the provision of quality

More information

County of Orange Health Care Agency. Orange County Mortality Data, 2002

County of Orange Health Care Agency. Orange County Mortality Data, 2002 County of Orange Health Care Agency Orange County Mortality Data, 2002 October 2005 Prepared by: County of Orange Health Care Agency Disease Control & Epidemiology Division Epidemiology & Assessment Juliette

More information

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999 Menzies Centre for Population Health Research University of Tasmania Tasmanian Cancer Registry 17 Liverpool

More information

ICD9_1 ICD9_2 ICD9_3 ICD9_4 ICD9_5 ICD9_6 ICD9_7 ICD9_8 ICD9_9 ICD9_10 ICD9_11 ICD9_12 ICD9_13 ICD9_14 ICD9_15

ICD9_1 ICD9_2 ICD9_3 ICD9_4 ICD9_5 ICD9_6 ICD9_7 ICD9_8 ICD9_9 ICD9_10 ICD9_11 ICD9_12 ICD9_13 ICD9_14 ICD9_15 Pediatric Medical Complexity Algorithm Code List for Version 2.0 ICD 9 list with assignment of body system and progressive status May 2015 (The umbrella code indicates that the listed codes include all

More information

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-. JAMA. doi:10.1001/jama.2016.4151.

More information

What is the problem, and how big is it?

What is the problem, and how big is it? Rare cancers What is the problem, and how big is it? Rare (orphan) diseases NIH Office for Rare Diseases Prevalence less than 5/10 000 in the community In the US

More information

GLOBAL P4P. Pay for Performance (P4P) Program Guide

GLOBAL P4P. Pay for Performance (P4P) Program Guide GLOBAL P4P Pay for Performance (P4P) Program Guide Contact: QualityPrograms@iehp.org Published: March 28, 2018 PROGRAM OVERVIEW This program guide provides an overview of the 2018 Global Quality Pay for

More information

Episodes of Care Risk Adjustment

Episodes of Care Risk Adjustment Episodes of Care Risk Adjustment Episode Types Wave 1 Asthma Acute Exacerbation Perinatal Total Joint Replacement Wave 2 Acute Percutaneous Coronary Intervention COPD Acute Exacerbation Non-acute Percutaneous

More information

Cancer in Colorado Incidence, Mortality, and Survival

Cancer in Colorado Incidence, Mortality, and Survival Cancer in Colorado 1998-2003 Incidence, Mortality, and Survival Jack L. Finch, M.S. Statistical Analyst III Kieu O. Vu, M.S.P.H. Statistical Analyst II 2007 Colorado Central Cancer Registry Randi K. Rycroft,

More information

AZITHROMYCIN TREATMENT FOR STDS

AZITHROMYCIN TREATMENT FOR STDS AZITHROMYCIN TREATMENT FOR STDS Azithromycin Treatment For Stds For sale usa azithromycin 500 chlamydien azithromycin einnahme Azithromycin condition mg 250 Sinus infection azithromycin help For 250 mg

More information

GlobalHealth has improved ratings in the following HEDIS measures: Antidepressant Medication Management Continuation Phase

GlobalHealth has improved ratings in the following HEDIS measures: Antidepressant Medication Management Continuation Phase August 2013, Dear GlobalHealth Network Practitioners and Providers: Each year, GlobalHealth selects and examines a sample of medical records to ensure quality care is being provided to our members. These

More information

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 3 Episodes

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 3 Episodes TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 3 Episodes Respiratory Infection (RI); Pneumonia (PNA); Inpatient Urinary Tract Infection (UTI-I; Outpatient Urinary

More information

INDEX FOR 3 AND 4 DIGIT DIAGNOSTIC CODES (ICD9)

INDEX FOR 3 AND 4 DIGIT DIAGNOSTIC CODES (ICD9) INDEX FOR 3 AND 4 DIGIT DIAGNOSTIC CODES (ICD9) INFECTIONS AND PARASITIC DISEASES 001-009.3 Intestinal and Infectious Diseases 010-018.9 Tuberculosis 020-027.9 Zoonotic Bacterial Diseases 030-041.9 Other

More information

Research Article Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program

Research Article Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program Hindawi Publishing Corporation Journal of Cancer Epidemiology Volume 2014, Article ID 437971, 18 pages http://dx.doi.org/10.1155/2014/437971 Research Article Cancer Incidence in Egypt: Results of the National

More information

SKCC Protocol Review Committee New Study Application

SKCC Protocol Review Committee New Study Application Instructions: Submit the following documents to prc@jefferson.edu - Completed New Study Application (aka MCSF) - Protocol - Protocol Facilitation Committee Approval (if applicable) - MDG Priority Score

More information

Chapter 1: Certain Infectious and parasitic diseases (A00-B99)

Chapter 1: Certain Infectious and parasitic diseases (A00-B99) ICD-10-CM Part 5 Chapter 1: Certain Infectious and parasitic diseases (A00-B99) New sub-chapter: Infections with a predominantly sexual mode of transmission (A50-A64) You will not find: septicemia - rather,

More information

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind

More information

AZITHROMYCIN 40 MG ML

AZITHROMYCIN 40 MG ML AZITHROMYCIN 40 MG ML Azithromycin 40 Mg Ml Azithromycin and medicine allergy cipro For work long to cats how azithromycin Azithromycin doses for chlamydia Treatment 250 uses mg azithromycin Z instructions

More information

Cancer in Central and South America BOLIVIA

Cancer in Central and South America BOLIVIA Cancer in Central and South America BOLIVIA This country profile for the Cancer in Central and South America project provides, for each participating cancer registry tables and graphics showing numbers

More information

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication

More information

LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013

LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 Landmark Medical Center offers a comprehensive cancer care services to our patients. LMC Cancer program is committed to ensure that patients receive

More information

Cancer Incidence in New Jersey Implementation of the Year 2000 Population Standard

Cancer Incidence in New Jersey Implementation of the Year 2000 Population Standard Cancer Incidence in New Jersey 1995-1999 Implementation of the Year 2000 Population Standard Prepared by: Stasia S. Burger, MS, CTR Judith B. Klotz, MS, DrPH Rachel Weinstein, MS, PhD Toshi Abe, MSW, CTR

More information

POLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

POLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS POLICY F TREATMENT OF UPPER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: June 2018 Approved by: Date: July 2018 The Drugs & Therapeutics Committee Implementation

More information

Choosing an appropriate antimicrobial agent. 3) the spectrum of potential pathogens

Choosing an appropriate antimicrobial agent. 3) the spectrum of potential pathogens Choosing an appropriate antimicrobial agent Consider: 1) the host 2) the site of infection 3) the spectrum of potential pathogens 4) the likelihood that these pathogens are resistant to antimicrobial agents

More information

Cancer Treatment Centers of America ATLANTA CANCER REGISTRY. Annual Report

Cancer Treatment Centers of America ATLANTA CANCER REGISTRY. Annual Report Cancer Treatment Centers of America ATLANTA CANCER REGISTRY Annual Report CANCER COMMITTEE Chairman s Report On behalf of the Cancer Committee a multidisciplinary team of boardcertified physicians and

More information

Both adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members)

Both adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members) Infectious Diseases Society of America Emerging Infections Network Report for Query: Antimicrobial Drug Shortages 2016 Overall response rate: 701/1,597 (44%) physicians responded from 3/22/16 to 4/13/16.

More information

LCD for Interferon (L29202)

LCD for Interferon (L29202) LCD for Interferon (L29202) Contractor Name First Coast Service Options, Inc. Contractor Number 09102 Contractor Type MAC - Part B Contractor Information LCD ID Number L29202 LCD Information LCD Title

More information

CANCER REGISTRY Annual Report

CANCER REGISTRY Annual Report CANCER REGISTRY Annual Report 2017 Cancer Treatment Centers of America at Southeastern Regional Medical Center Atlanta, Georgia Philadelphia, Pennsylvania Chicago, Illinois Tulsa, Oklahoma Phoenix, Arizona

More information

Appendix A: Definitions for Cancer Incidence Data

Appendix A: Definitions for Cancer Incidence Data Appendices Cancer in Minnesota, 1988-2002 231 Appendix A: Definitions for Cancer Incidence Data MCSS collects information on all microscopically confirmed malignant and in situ tumors diagnosed in Minnesota

More information

Arkansas Health Care Payment Improvement Initiative COPD Algorithm Summary

Arkansas Health Care Payment Improvement Initiative COPD Algorithm Summary Arkansas Health Care Payment Improvement Initiative COPD Algorithm Summary Chronic Obstructive Pulmonary Disease (COPD) Algorithm Summary v1.6 Page 2 of 6 Triggers PAP Assignment Exclusions Episode Time

More information

Table of Contents. Last updated by CLO: 5/8/2013 1

Table of Contents. Last updated by CLO: 5/8/2013 1 Table of Contents Drug-induced liver injury algorithm - Cases... 2 Drug-induced liver injury algorithm - Controls... 3 1. Summary of drug-induced liver injury algorithm... 4 2. Terminology... 4 3. Threshold

More information

Cancer survival in Hong Kong SAR, China,

Cancer survival in Hong Kong SAR, China, Chapter 5 Cancer survival in Hong Kong SAR, China, 1996 2001 Law SC and Mang OW Abstract The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods.

More information

GLOBAL P4P. Pay for Performance (P4P) Program Guide

GLOBAL P4P. Pay for Performance (P4P) Program Guide GLOBAL P4P Pay for Performance (P4P) Program Guide Contact: QualityPrograms@iehp.org Published: January 10, 2018 PROGRAM OVERVIEW IEHP is pleased to provide an update for the Global Quality Pay for Performance

More information

UnitedHealth Premium Physician Designation Program Episode Treatment Groups (ETG ) Description and Specialty

UnitedHealth Premium Physician Designation Program Episode Treatment Groups (ETG ) Description and Specialty UnitedHealth Premium Physician Designation Program Episode Treatment Groups (ETG ) Description and Specialty 666700 Acne Family Medicine, Internal Medicine, Pediatrics 438300 Acute Bronchitis Allergy,

More information

2013 NATIONAL COVERAGE DETERMINATION (NCD) CPT CODE(S): 82728, 83540, 83550, IRON - SERUM

2013 NATIONAL COVERAGE DETERMINATION (NCD) CPT CODE(S): 82728, 83540, 83550, IRON - SERUM 790.01-790.09 ABNORMALITY OF RED BLOOD CELLS 572.0 ABSCESS OF LIVER 570 ACUTE AND SUBACUTE NECROSIS OF LIVER 207.02 ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA, IN RELAPSE 207.00-207.01 ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA,

More information

Supplementary materials for:

Supplementary materials for: Supplementary materials for: Cecil E, Bottle A, Sharland M, Saxena S. Impact of UK primary care policy reforms on short-stay unplanned hospital admissions for children with primary care-sensitive conditions.

More information

Tables e1a-d. Diagnostic and drug codes for the identification of the multiple sclerosis population, DMT exposures, and study outcomes

Tables e1a-d. Diagnostic and drug codes for the identification of the multiple sclerosis population, DMT exposures, and study outcomes Appendix Tables e1a-d. Diagnostic and drug codes for the identification of the multiple sclerosis population, DMT exposures, and study outcomes Table e-1a Multiple sclerosis and demyelinating disease related

More information

Toward a Diagnosis Driven (Dental) Profession through Controlled Terminology

Toward a Diagnosis Driven (Dental) Profession through Controlled Terminology Toward a Diagnosis Driven (Dental) Profession through Controlled Terminology James J. Cimino, MD Director, Informatics Institute University of Alabama at Birmingham Birmingham, Alabama, USA Los Angeles,

More information

Diagnosis and Treatment of Respiratory Illness in Children and Adults

Diagnosis and Treatment of Respiratory Illness in Children and Adults Page 1 of 9 Main Algorithm Annotations 1. Patient Reports Some Combination of Symptoms Patients may present for an appointment, call into a provider to schedule an appointment or nurse line presenting

More information